欧洲精品一区二区三区_欧美性性性性_国产一区二区免费在线播放_日日噜噜噜噜人人爽日本精品_无套中出丰满人妻无码_国产偷窥熟女精品视频大全

美國Accumetrics  
Accumetrics 致力于通過提供業界領先且廣泛可用的快速評估血小板功能的診斷檢測方法，來促進醫學界對血小板功能的了解，并提高對正在接受抗血小板治療的患者的護理質量。

Accumetrics 的 VerifyNow System 是幫助醫生判定個體患者對多種抗血小板藥物反應的首個快速且易于使用的平臺。VerifyNow System 適用于各種主要的抗血小板藥，包括獲得 FDA 批準的阿司匹林產品、P2Y12 抑制劑（如 prasugrel (Effient) 和 clopidogrel (Plavix)）、以及 GP IIb/IIIa 抑制劑（如 ReoPro(R) 和 Integrilin(R)），提供了一種可以幫助醫生做出明智治療決定的寶貴工具。

Accumetrics is at the forefront of revolutionizing the way doctors manage the tens of millions of patients who take antiplatelet drugs to prevent heart attack, stroke and other potentially life-threatening cardiovascular events.

Accumetrics is a privately-held company based in San Diego, California. The company develops, manufactures, and markets the VerifyNow? System, a comprehensive suite of tests for the assessment of platelet response to antiplatelet therapies. The tests are fully automated and easy-to-use allowing physicians an accurate way to assess platelet response to optimize the effectiveness of antiplatelet therapies, and to guide treatment decisions in patients who may be at risk of a life threatening thrombosis event or bleeding complication.